International Stem Cell GAAP EPS of -$0.03, revenue of $9.09M
Source: SeekingAlpha
2025-03-31 10:23:04 ET
More on International Stem Cell
Read the full article on Seeking Alpha
For further details see:
International Stem Cell GAAP EPS of -$0.03, revenue of $9.09M
International Stem Cell Corp
NASDAQ: ISCO
ISCO Trading
10.3% G/L:
$0.1761 Last:
20,809 Volume:
$0.15966 Open:
ISCO Latest News
March 31, 2025 08:30:00 am
International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results
ISCO Stock Data
$1,320,724
1,323,925
13.31%
5
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
